MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, C.-C.
Right arrow Articles by Hsu, K.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, C.-C.
Right arrow Articles by Hsu, K.-S.

Vol. 61, Issue 3, 578-585, March 2002

Activation of cAMP-Dependent Protein Kinase Suppresses the Presynaptic Cannabinoid Inhibition of Glutamatergic Transmission at Corticostriatal Synapses

Chiung-Chun Huang, Yea-Lin Chen, Shiow-Win Lo, and Kuei-Sen Hsu

Department of Pharmacology, College of Medicine, National Cheng-Kung University, Taiwan, Republic of China

In a previous study, we showed that type 1 cannabinoid (CB1) receptor activation substantially depresses the corticostriatal glutamatergic transmission onto striatal neurons in the brain slice preparation. We now report that the adenylyl cyclase activator forskolin and cAMP analog (S)-p-8-(4-chlorophenythil) adenosine-3',5'-monophosphorothioate (Sp-8-CPT-cAMPS) strongly suppressed the synaptic depression induced by cannabimimetic aminoalkylindole, WIN 55,212-2. Application of the cAMP-dependent protein kinase (PKA) inhibitor KT5720 alone had no consistent effect on basal synaptic transmission but the synaptic enhancement elicited by forskolin was blocked. In addition, pretreatment of striatal slices with either KT5720 or another PKA inhibitor, H89, completely abolished the attenuation by forskolin on WIN 55,212-2-induced synaptic depression. The effect of forskolin on CB1 receptor function was still observed in a low Ca2+ bathing solution, suggesting that the forskolin's action is not attributable to its ability to saturate the presynaptic transmitter release processes. The possibility that forskolin acted by increasing CB1 receptor phosphorylation was confirmed by demonstrating that the serine-phosphorylated component with CB1 receptors was significantly increased after forskolin treatment. This forskolin effect was markedly attenuated in the presence of KT5720. Moreover, the activation of beta -adrenergic receptors by isoproterenol mimics forskolin to elicit a PKA-dependent inhibition of CB1 receptor function. Together, these observations indicate that the presynaptic inhibitory action of CB1 receptors at corticostriatal synapses could be negatively regulated by cAMP/PKA-mediated receptor phosphorylation. This effect of PKA may play a functional role in fine-tuning glutamatergic transmission at corticostriatal synapses.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg
Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity
Mol. Pharmacol., March 1, 2006; 69(3): 691 - 696.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg
Involvement of Protein Kinase A in Cannabinoid Receptor-Mediated Protection from Oxidative Neuronal Injury
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 88 - 94.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. Dinis, A. Charrua, A. Avelino, M. Yaqoob, S. Bevan, I. Nagy, and F. Cruz
Anandamide-Evoked Activation of Vanilloid Receptor 1 Contributes to the Development of Bladder Hyperreflexia and Nociceptive Transmission to Spinal Dorsal Horn Neurons in Cystitis
J. Neurosci., December 15, 2004; 24(50): 11253 - 11263.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Melis, M. Pistis, S. Perra, A. L. Muntoni, G. Pillolla, and G. L. Gessa
Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors
J. Neurosci., January 7, 2004; 24(1): 53 - 62.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
T. F. FREUND, I. KATONA, and D. PIOMELLI
Role of Endogenous Cannabinoids in Synaptic Signaling
Physiol Rev, July 1, 2003; 83(3): 1017 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
V. S. Seybold, K. E. McCarson, P. G. Mermelstein, R. D. Groth, and L. G. Abrahams
Calcitonin Gene-Related Peptide Regulates Expression of Neurokinin1 Receptors by Rat Spinal Neurons
J. Neurosci., March 1, 2003; 23(5): 1816 - 1824.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Arima, S. B. House, H. Gainer, and G. Aguilera
Neuronal Activity Is Required for the Circadian Rhythm of Vasopressin Gene Transcription in the Suprachiasmatic Nucleus in Vitro
Endocrinology, November 1, 2002; 143(11): 4165 - 4171.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics